Clinical Trials Browser

Phase 2 × fluoromisonidazole × CNS × Clear all

NCT03649880 2025-03-25

Feasibility of FMISO in Brain Tumors

Phase 2 Recruiting

Brain Neoplasms

NCT00902577 2019-04-08

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 2 Completed

50 enrolled 16 charts

Glioblastoma, Gliosarcoma

NCT01868906 2018-08-24

FMISOPETSCS

Phase 2 Terminated

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma